INS and type 2 diabetes mellitus: C-peptide is nearly undetectable in patients with T1DM and even in patients with T2DM patients, depending on the level of residual endogenous insulin production,[22] duration of DM, honeymoon period, drug treatment, degree of autoimmunity, and IR.